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Severe preterm preeclampsia – associated posterior reversible encephalopathy 
syndrome 
 
Teška preeklampsija u nedonošenoj trudnoći, uz pojavu reverzibilnog encefalopatičnog 
sindroma 
 




Posterior reversible encephalopathy syndrome (PRES) is a clinical syndrome which causes non-specific 
neurological symptoms such as visual impairment (cortical blindness, diplopia, hemianopia), acute headaches, 
seizures (focal or general tonic-clonic), vomiting, altered mental status, focal neurologic deficit as a 
complication of preeclampsia. Preeclampsia is a serious complication specific for pregnancy, characterized 
by hypertension (systolic > 140 mm Hg and/or diastolic > 90 mm Hg) and proteinuria (> 300 mg u 24-h urine 
sample , > 1 +) at or after 20th week of gestation. It is one of the leading causes of perinatal morbidity and 
mortality. We present a 38-year-old pregnant woman, gravida 1 para 0 with PRES which was manifested on 
the second day after delivery by Cesarean section at 32 weeks of gestation with aphasia and blindness caused 
by severe preeclampsia. We confirmed the diagnosis by MRI which revealed white matter edema in the 
posterior cerebral area in a symmetric fashion, hyper intense cortical foci in the right occipital lobe and 
punctiform lesions in the bilateral occipital lobe. We treated her promptly in the intensive care unit (ICU) with 
antihypertensive and anticonvulsant therapy after which she fully recovered. PRES should always be kept in 
mind when a patient in the postpartum period develops one of the above symptoms. If timely recognized and 
promptly treated, full recover usually follows. 




Posteriorni reverzibilni, encefalopatični sindrom (PRES) klinički je sindrom karakteriziran nespecifičnim 
neurološkim simptomima, kao što su smetnje vida (sljepilo, dvostruki vid, gubitak polovine vidnoga polja), 
akutna glavobolja, epileptički napadaji (fokalni ili generalizirani toničko-klonički grčevi), povraćanje, 
izmijenjena stanja svijesti, fokalni neurološki deficiti, u ovom slučaju preeklampsije kao komplikacija. 
Preeklampsija (PE) je poremećaj specifičan za trudnoću, karakteriziran pojavom hipertenzije (sistolički tlak > 
140 mm Hg i/ili dijastolički tlak > 90 mm Hg) udružene s proteinurijom (> 300 mg u 24-h urinu, > 1 +) koji 
nastaje nakon 20. tjedna gestacije u prethodno normotenzivnih žena, bez proteinurije. Vodeći je uzrok 
maternalnog i perinatalnog morbiditeta i mortaliteta. U ovom radu prikazujemo slučaj 38-godišnje trudnice, 
prvorotke, sa simptomima PRES-a koji su se manifestirali gubitkom sposobnosti govora i sljepoćom drugog 
dana nakon poroda carskim rezom, koji je urađen zbog teške preeklampsije s točno 32 tjedna gestacije. 
Dijagnozu smo potvrdili magnetskom rezonancom (MR) koja je pokazala simetričan edem bijele tvari u 
posteriornim područjima mozga, područja hiperintenziteta u desnom okcipitalnom režnju i punktiformne 
lezije obostrano okcipitalno. Bolesnicu smo odmah prebacili u jedinicu intenzivne njege, gdje je tretirana 
antihipertenzivnom i antikonvulzivnom terapijom, nakon koje se za nekoliko dana u potpunosti oporavila. 
Treba uvijek razmišljati o PRES-u kada bolesnica u razdoblju nakon poroda razvije jedno od gore navedenih 
simptoma. Ukoliko se na vrijeme prepozna i tretira obično uslijedi potpuni oporavak. 
Ključne riječi: PRES, teška preeklampsija, rano poslijeporođajno razdoblje, sljepoća, nijemost 
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The posterior reversible encephalopathy syndrome 
(PRES) is a condition characterized by acutely altered 
mentation, drowsiness or sometimes stupor, visual 
impairment (e. g. visual hallucinations, cortical 
blindness, hemianopia, qudrantanopia, and diplopia), 
seizures, and sudden or constant, non-localized 
headaches.1 The PRES acronyme derives from 
findings on magnetic resonance imaging (MRI) 
including white matter edema found in the posterior 
cerebrum, and the fact that symptoms are reversible, 
provided that the syndrome is recognized and treated 
promptly.2 The pathophysiology of PRES is still not 
fully understood, although people who are at risk for 
developing PRES tend to have one or more risk factors, 
such as: preeclampsia, hypertension, renal failure, liver 
disease, autoimmune disorders and sepsis.2,3,4 The 
most common cause is uncontrolled drug resistant 
hypertension.5 Preeclampsia also is acknowledged to 
be an important cause of PRES.6 It affects people of all 
ages, from children to old adults, but most frequently 
young or middle age females which might be 
attributable to etiological aspects. Since the syndrome 
is significantly underdiagnosed, epidemiological data 
should be interpreted with caution.1 PRES seems to be 
linked to failure of cerebral blood flow autoregulation, 
the brain’s ability to maintain constant cerebral blood 
flow over a range of blood pressure via the constriction 
or dilatation of the cerebral blood vessels.2 The second 
theory regarding the cause of PRES is that the 
syndrome is triggered by endothelial dysfunction 
caused by circulating endogenous or exogenous 
toxins.1 The third theory include a possible patho-




The patient has provided informed consent for the 
publication of the case. A previously healthy pregnant 
38-year-old woman (gravida 1 para 0) presented to our 
hospital at 29th week of gestation with preeclampsia. 
The family history showed that both her mother and 
father suffered from hypertension. She was treated 
with methyldopa and amlodipin. Despite the therapy of 
methyldopa 2g and amlodipin 10 mg per day the blood 
pressure on 32nd week of gestation was elevated, up to 
180/110 mm/Hg with proteinuria 2g/24 hour. A lab 
panel showed slightly elevated liver enzymes and low 
proteins (AST 56 U/L, ALT 63 U/L, total protein 50 
g/L) while other parameters were normal. Fetal 
monitoring with cardiotocography showed signs of 
fetal distress. She received steroids (dexamethason 8 
mg per two days) for fetal lung maturation and 
magnesium (4g intravenous over 30 minutes then 2 
g/hour next 12h) for fetal brain neuroprotection. 
Considering drug resistant hypertension on exactly 
32nd week of gestation, she underwent an emergent 
uncomplicated Cesarean section and she delivered a 
female baby, 1440 g weight and 36 cm long. Apgar 
score in the first minute was 5 and the baby was 
transferred to the Neonatal Ward. Two days after 
Cesarean section, she experienced a sudden 
consciousness disturbance which was followed by 
amaurosis, aphasia, perseveratio, agitatio. The patient's 
vital signs included high blood pressure, 180/110 
mm/Hg although antihypertension therapy was 
administred the whole time. Heart rate was 120 bpm, 
respiration rate was12 breaths per minute, SpO2 was 
91%, and body temperature was 37ºC. A lab panel 
showed slightly elevated liver enzymes and low 
proteins (AST 70 U/L, ALT 69 U/L, total protein 52 
g/L). The diagnosis of PRES was considered. She was 
transferred to the Intensive Care Unit of our hospital 
for further management. Immediate rescue measures 
included: oxygen administration, urapidil 25 mg 
intravenous bolus, followed by continuous intravenous 
drip 25 mg/hour, magnesium sulfate 5g intravenous 
bolus, followed by continuous intravenous drip 1.5 
g/hour, dexamethason 8 mg intravenously and 
levetiracetam 500 mg twice daily. Brain T2-weighted 
MRI showed hyperintense cortical foci in the right 
occipital lobe and punctiform lesions in the bilateral 
occipital lobe (Figure 1). Cardiologic investigations 
did not show remarkable findings. Her neurological, 
visual and speech functions gradually improved after 
24 hours and the blood pressure stabilized so she 
continued undergoing antihypertension therapy, 
methyldopa 2 g and amlodipin 10 mg per day. Twelve 
days after delivery, she was discharged in good 
condition with stabile blood pressure and reduced 




Posterior reversible encephalopathy syndrome is a 
severe condition that has been underdiagnosed, but 
owing to the improvement in the quality of imaging, 
understanding of PRES has improved.7 In the case 
described here, the patient showed neurological 
disorder, second day after undergoing Cesarean 
section, especially visual impairment and aphasia that 
lasted for nearly 24 hours, which was connected with 
preeclampsia. Patients with preeclampsia and PRES 
may have other abnormalities such as liver enzymes 
irregularities, decrease of platelets which were not 
observed in the present case.2 After diagnostic and 
therapeutic procedures, the diagnosis of PRES was 
established. Brain MRI is the most suitable diagnostic 
tool.8 It was important that PRES was differentiated 
Benzon S et al. Severe preterm preeclampsia – associated posterior reversible  ...   – Med Jad 2020;50(4):349-352 
 
 351 
from other diseases such as ischemic stroke and 
thrombosis of the cerebral venous sinus since it is the 
most frequent cerebrovascular disorder in the 
puerperium.9 The diagnosis has important therapeutic 
and prognostic implications because the reversibility of 
the clinical and radiologic abnormalities is contingent 
on the prompt control of blood pressure and/or 
discontinuing of the offending drug.10 Admission to a 
critical care unit is required in about 40% of patients due 
to complicating conditions including status epilepticus, 
cerebral vasoconstriction, ischemia or intracerebral 
hemorrhage. Prognosis is favorable; in the majority of 
patients neurological deficits and imaging findings 
resolve completely.1 Hypertension has to be treated 
using antihypertensive drugs and magnesium sulphate 
should be used to prevent seizures.7 Delayed treatment 
might result in permanent brain damage so awareness 
and education are cornerstones for the proper 
management of PRES, which should be kept in mind in 





Figure 1 Brain MRI demonstrate hyperintensities in the occipital cortex 
MRI – magnetic resonance imaging 
Slika 1. MR mozga s hiperintenzitetima u okcipitalnom korteksu 
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